PARP Inhibitors in Ovarian Cancer
N Engl J Med
.
2020 Apr 16;382(16):1573-1574.
doi: 10.1056/NEJMc2000644.
Author
Tim J A Dekker
1
Affiliation
1
Haaglanden Medisch Centrum, The Hague, the Netherlands t.j.a.dekker@gmail.com.
PMID:
32294363
DOI:
10.1056/NEJMc2000644
No abstract available
Publication types
Letter
Comment
MeSH terms
Bevacizumab
Female
Humans
Ovarian Neoplasms*
Phthalazines
Piperazines
Poly(ADP-ribose) Polymerase Inhibitors*
Substances
Phthalazines
Piperazines
Poly(ADP-ribose) Polymerase Inhibitors
Bevacizumab
olaparib